Aboud O., Mrak R. E., Boop F. and Griffin S. T. (2012). Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience. BMC Medicine, 10, 35–44. doi:10.1186/1741-7015-10-35.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Publishing.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Publishing.
Anderson K. N. and Bradley A. J. (2013). Sleep disturbance in mental health problems and neurodegenerative disease. Nature & Science of Sleep, 561–575. doi: 10.2147/NSS.S34842.
et al. (2013). State dependent changes in hippocampal grey matter. Molecular Psychiatry, 18, 1265–1272.
Massey H., Lamb H. and Morris C. (1997). Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry, 63, 273–273. doi: 10.1136/jnnp.63.2.273b
Barnes D. and Yaffe K. (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurology, 10, 819–828. doi: 10.1016/S1474-4422(11)70145-4.
et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367, 795–804.
Belsky D. W., Moffitt T. E. and Caspi A. (2013). Genetics in population health science: strategies and opportunities. American Journal of Public Health, 103
Brainerd C. J., Reyna V. F., Petersen R. C., Smith G. E. and Taub E. S. (2011). Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology, 25, 679–689. doi: 10.1037/a0024483.
Brainerd C. J.
et al. (2013). The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study. Neuropsychology, 27, 86–94. doi: 10.1037/a0030855.
Buckley J. D. (1984). Additive and multiplicative models for relative survival rates. Biometrics, 40, 51–62.
Cantillon M., Barker W., Harwood D., Mullan M. and Duara R. (1996). Phenotype of depression in Alzheimer's disease (AD) with APOE genotype. Biological Psychiatry, 39, 661.
Caraci F., Copani A., Nicoletti F. and Drago F. (2010). Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. European Journal of Pharmacology, 626, 64–71.
Chui H. C., Zheng L., Reed B. R., Vinters H. V. and Mack W. J. (2012). Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimer's Research and Therapy, 4, 1–13. doi:10.1186/alzrt98.
Corder E. H.
et al. (1993). Gene dose of apolipoprotein E type allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.
Corder E. H.
et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 181–184.
Cox D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society, Series B, 34, 187–220.
Cummings J. L. (1997). The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology, 48, S10–S16.
de-Almada B. V. P.
et al. (2012). Protective effect of the APOE-e3 allele in Alzheimer's disease. Brazilian Journal of Medical and Biological Research, 45, 8–12.
de Oliveira F. F., Ferreira Bertolucci P. H., Chen E. S. and Smith M. C. (2014). Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia. Neurology India, 62, 625–630. doi:10.4103/0028-3886.149384.
Donix M., Small G. W. and Bookheimer S. Y. (2012). Family history and APOE-4 genetic risk in Alzheimer's disease. Neuropsychological Review, 22, 298–309. doi: 10.1007/s11065-012-9193-2.
Efron B. (1977). The efficiency of Cox's likelihood function for censored data. Journal of the American Statistical Association, 72, 557–565.
Farrer L. A.
et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA, 278, 1349–1356.
Fortune D. A., Lang R., Cook S. and Byrd G. S. (2013). African Americans and Alzheimer's disease: role of health educators in addressing this silent epidemic. American Journal of Health Studies, 28, 92–100.
et al. (2011). A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clinical Medicine & Research, 9, 17–25. doi: 10.3I2l/cmr.20I0.894.
Gil-Bea F. J.
et al. (2010). HPA axis dysregulation associated to apolipoprotein e4 genotype in Alzheimer's disease. Journal of Alzheimer's Disease, 22, 829–838. doi: 10.3233/JAD-2010-100663.
Harwood D. G., Barker W. W., Ownby R. L., Mullan M. and Duara R. (2004). No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly. International Journal of Geriatric Psychiatry, 19, 1131–1139. doi:10.1002/gps.1193.
Hollingworth P., Harold D., Jones L., Owen M. J. and Williams J. (2011). Alzheimer's disease genetics: current knowledge and future challenges. International Journal of Geriatric Psychiatry, 26, 793–802. doi: 10.1002/gps.2628.
et al. (2006). Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. Journal of the American Geriatrics Society, 54, 1348–1354.
Kaufer D. I.
et al. (2000). Validation of the NPI-Q: a brief clinical form of the neuropsychiatric inventory. The Journal of Neuropsychiatry and Clinical Neurosciences, 12, 233–239.
Kleinbaum D. G. and Klein M. (2012). Survival Analysis: A Self-Learning Text, 3rd edn. New York: Springer.
Kumar A. and Chanana P. (2014). Sleep reduction: a link to other neurobiological diseases. Sleep and Biological Rhythms, 12, 150–161. doi:10.1111/sbr.12066.
Lee H. J. and Dugan E. (2015). How large is the gap between self-report and assessed mental health and does it impact older adult mental health service utilization?. Journal of Gerontological Social Work, 58, 3–19. doi:10.1080/01634372.2014.919978.
Lim A., Yu L., Kowgier M., Schneider J., Buchman A. and Bennett D. (2013). Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurology, 70, 1544–1551. doi:10.1001/jamaneurol.–.4215.
López-León S. S.
et al. (2008). Meta-analyses of genetic studies on major depressive disorder. Molecular Psychiatry, 13, 772–785. doi:10.1038/sj.mp.4002088.
et al. (2015). Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger and older adults. Psychosomatic Medicine, 77, 480–492. doi: 10.1097/PSY.0000000000000190.
Lyketsos C. G. and Olin J. (2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243–252.
Marques S. F., Oliveira C. R., Outeiro T. F. and Pereira C. F. (2010). Alzheimer's disease: the quest to understand complexity. Journal of Alzheimer's Disease, 21, 373–383. doi:10.3233/JAD2010100303.
McKhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939–944.
et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 263–269. doi:10.1016/j.jalz.2011.03.005.
Mendelsohn A. R. and Larrick J. W. (2013). Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuvenation Research, 18, 518–523. doi: 10.1089/rej.2013.1530.
Meng X. and D'Arcy C. (2013). Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. International Journal of Geriatric Psychiatry, 28, 1005–1014. doi: 10.1002/gps.3918.
Morris J. C.
et al. (2006). The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer's disease centers. Alzheimer Disease and Associated Disorders, 20, 210–216.
Multhammer M., Michels A., Zintl M., Mendoza M. C. and Klünemann H. H. (2014). A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease. Acta Neurologica Belgica, 114, 25–31.
Nikodemova M., Finn L., Mignot E., Salzieder N. and Peppard P. E. (2013). Association of sleep disordered breathing and cognitive deficit in APOE Ɛ4 carriers. Sleep, 36, 873–880. doi:10.5665/sleep.2714.
Osorio R. S.
et al. (2014). The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiology of Aging, 35, 1318–1324. doi:10.1016/j.neurobiolaging.2013.12.030.
Peavy G. M.
et al. (2007). The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biological Psychiatry, 62, 472–478.
Pistacchi M., Gioulis M., Contin F., Sanson F. and Marsala S. Z. (2014). Sleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patients. Journal of the Neurological Sciences. doi: 10.1007/s10072-014-1870-x.
Portney L. G. and Watkins M. P. (2009). Foundations of Clinical Research: Applications to Practice, 3rd edn. Upper Saddle River, NJ: Pearson Education, Inc.
Qiu C., Xu W., Winblad B. and Fratiglioni L. (2010). Vascular risk profiles for dementia and Alzheimer's disease in very old people: a population-based longitudinal study. Journal of Alzheimer's Disease, 20, 293–300. doi: 10.3233/JAD-2010-1361.
Reitz C., Tang M. X., Schupf N., Manly J. J., Mayeux R. and Luchsinger J. A. (2010). A summary risk score for the prediction of Alzheimer disease in elderly persons. Archives of Neurolology, 67, 835–841. doi: 10.1001/archneurol.2010.136.
et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467–1472.
Schipper H. M. (2011). Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiology of Aging, 32, 778–790. doi:10.1016/j.neurobiolaging.2009.04.021.
Segal A. Z. (2013). Poor sleep quality may predict preclinical Alzheimer's disease. Neurology Alert, 31, 86–88.
Sheline Y. I., Gado M. H. and Kraemer H. C. (2003) Untreated depression and hippocampal volume loss. American Journal of Psychiatry, 160, 1516–1519.
Sperling R. A.
et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 280–292. doi:10.1016/j.jalz.2011.03.003.
Spira A. P.
et al. (2013). Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurology, 70, 1537–1543.
StataCorp (2015). Stata Statistical Software: Release 14. College Station, TX: StataCorp LP.
Talbot C., Lendon C., Craddock N., Shears S., Morris J. C. and Goate A. (1994). Protection against Alzheimer's disease with APOE epsilon 2. Lancet, 343, 1432–1433.
Thies W. and Bleiler L. (2013). 2013 Alzheimer's disease facts and figures. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 9, 208–245. doi:10.1016/j.jalz.2013.02.003.
et al. (2013). Midlife sleep characteristics associated with late life cognitive function. Sleep, 36, 1533–1541. doi:10.5665/sleep.3052.
et al. (2009). The Alzheimer's disease centers’ uniform data set (UDS): the neuropsychological test battery. Alzheimer Disease and Associated Disorders, 23, 91. doi: 10.1097/WAD.0b013e31819c7dd.
Weldemichael D. A. and Grossberg G. T. (2010). Circadian rhythm disturbances in patients with Alzheimer's disease: a review. International Journal of Alzheimer's Disease, 2010, 1–9. doi:10.4061/2010/716453.
et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342, 373–377. doi:10.1126/science.1241224.
Yesavage J. A.
et al. (2004). Sleep/Wake disruption in Alzheimer's disease: APOE status and longitudinal course. Journal of Geriatric Psychiatry & Neurology, 17, 20–24. doi:10.1177/0891988703261994.